IGF2BP2 and neoplasm: In vivo experiments involving the subcutaneous implantation of sh-Control, sh-NAT10, and sh-IGF2BP2 CAL27 cells in nude mice demonstrated a significant decrease in tumor size with the interference of NAT10 and IGF2BP2 (p < 0.001) (Fig. 9A).